- Peter Thiel-backed Atai Life Sciences ATAI has launched a new portfolio company, Revixia Life Sciences.
- Revixia Life's primary mission is to develop Salvinorin A (SalA) to treat various mental health disorders.
- Derived from Salvia divinorum, SalA is a non-nitrogenous agonist of the kappa-opioid receptor with potential use in treatment-resistant depression, substance use disorder, and pain.
- "Due to SalA's short psychedelic effect, it will be an attractive option for those who would like psychedelic treatment but are unwilling or unable to participate in longer sessions," said Revixia CEO Glenn Short in a statement.
- "The shorter experience will allow for more practical administration and monitoring, which may even make it possible to attend psychotherapy sessions on the same day," he added.
- Salvia has historically been used by the Mazatec people in Oaxaca, Mexico, to treat various illnesses like diarrhea and headaches.
- Salvinorin A can indirectly influence the cannabinoid system without interacting with the 5-HT2A serotonin receptor, the main target for hallucinogens such as DMT and psilocybin.
- Clinical trials are expected to begin in 2H of 2022.
- Price Action: ATAI shares are down 2.20% at $13.64 during the market session on the last check Thursday.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.